Healthcare company Omega Healthcare Investors Inc (NYSE:OHI) stated on Tuesday its net income of USD72.2m (USD0.34 per common share) for the quarter ended 31 March 2019.
This marks a decrease in earnings when compared with net income of USD87.9m (USD0.42 per common share) for the corresponding period in 2018.
The company added the decline in net income for the quarter ended 31 March 2019 versus the prior year was primarily due to the reduction in gains on the sale of assets, an increase of costs related to the acquisition of MedEquities Realty Trust as well as an increase of of impairments
Operating revenues of USD223.7m were generated for the quarter ended 31 March 2019, up over operating revenues of USD220.2m for the same period in 2018.
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Lilly declares Q3 2026 dividend
Abbott declares quarterly dividend of USD0.63 per share
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Lilly declares Q2 2026 dividend
Collegium to acquire AZSTARYS from Corium Therapeutics
CVS Health announces quarterly dividend of USD0.665 per share
Convatec launches co-branded eakin freeseal ostomy seal in North America